Structure |
Chemical Name |
CAS |
MF |
|
1-(2,4-difluoro-6-hydroxyphenyl)prop-2-en-1-one |
|
|
|
1-(4-Fluorphenyl)-1,3-dihydro-1-[3-(methylamino)propyl]isobenzofuran-5-carbonitril |
62498-67-3 |
C19H19FN2O |
|
17-α,21-Dihydroxy-16-α-methylpregna-1,4,9(11)-trien-3,20-dion-21-acetat |
10106-41-9 |
C24H30O5 |
|
2-chloro-N-(2,4-dimethylphenyl)acetamide |
39106-10-0 |
C10H12ClNO |
|
Natrium-[2S-(2α,5α,6β)]-6-brom-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat |
73335-78-1 |
C8H9BrNNaO3S |
|
2-Amino-1-(3,4-dihydroxyphenyl)ethan-1-on |
499-61-6 |
C8H9NO3 |
|
Benzoic acid, 5-(aminosulfonyl)-2-[[[4-methoxy-3-(methoxycarbonyl)phenyl]sulfonyl]oxy]-, methyl ester |
2267259-70-9 |
C17H17NO10S2 |
|
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-2-methyl-7-oxo-, (S)- (9CI) |
129798-65-8 |
C13H9F2NO4 |
|
Sitagliptin EP Impurity 1 |
|
|
|
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-, (αS,3aR,4R,6R,7aS)-, 2,2,2-trifluoroacetate (1:1) |
2363753-29-9 |
C17H29BF3NO4 |
|
Beprostatin impurity 3 |
|
|
|
endo-(±)-8-Aza-8-isopropylbicyclo[3.2.1]oct-3-yl-(hydroxymethyl)phenylacetat |
22235-81-0 |
C19H27NO3 |
|
8,11-Dioxa-3,5-diazadodecanoic acid, 12-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-10-(hydroxymethyl)-2,6-bis(1-methylethyl)-7-oxo-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, (2S,6S)- |
1654737-35-5 |
C29H44N12O10 |
|
(1R,3r,5S,8R)-8-butyl-3-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-8-methyl-8-azabicyclo[3.2.1]octan-8-ium |
99571-66-1 |
C21H32NO3+ |
|
1,3-dihydro-1-oxoisobenzofuran-5-carboxamide |
85118-25-8 |
C9H7NO3 |
|
(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-6H-purin-6-one |
2446799-72-8 |
C25H28N8O2 |
|
Troxipide Impurity 8 |
|
|
|
Peramivir Impurity 12/11 |
|
|
|
(1S,2R,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid |
|
|
|
Ceftazidime Impurity IMPA |
|
|
|
Pitavastatin Impurity 82 |
|
|
|
NA |
|
|
|
Peramivir Intermediate impurity 2 |
|
|
|
Cetrorelix Impurity 8 (+L-Pro) |
|
|
|
Peramivir Intermediate Impurity 44 |
|
|
|
Peramivir Hydroxy Isomeric Impurity |
|
|
|
Nintedanib impurity F drops |
|
|
|
Favipiravir Impurities 1-19 |
|
|
|
Ticagrelor Impurity 138X |
|
|
|
Pranoprofen Impurity C |
|
|
|
Deerasirox Impurity II |
|
|
|
Brivaracetam Impurity 49 |
|
|
|
Paroxetine EP Impurity J HCl |
|
|
|
Brivaracetam Impurity 99 |
|
|
|
Bendamustine Impurity 39 |
|
|
|
(R)-4-(((R)-1-carboxy-2-((3-hydroxypropyl)thio)ethyl)amino)-3-hydroxy-4-oxobutanoic acid |
|
|
|
Hydrazinecarboxamide, 2-(6-hydroxy-1-methyl-1H-indol-5-yl)- |
70063-07-9 |
C10H12N4O2 |
|
1H-Pyrrole-3-carboxaldehyde, 1-[(5-chloro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)- |
2514742-82-4 |
C16H10ClFN2O3S |
|
Crisaborole Impurity 20 |
|
|
|
(Z)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide |
|
|
|
(1S,3R,5S,6R)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
|
|
|
Nicergoline EP Impurity IJ |
|
|
|
Fulvestrant impurityABCDEFGHJKL |
|
|
|
2-((6S,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate |
114696-04-7 |
C24H36O6 |
|
Isavuconazole Impurity 49 |
|
|
|
(R)-5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-methoxyethyl)-8-hydroxyquinolin-2(1H)-one |
|
|
|
Tafluprost Impurity 18 |
|
|
|
Rosuvastatin Impurity 161 |
|
|
|
Rosuvastatin Impurity 155 |
|
|
|
Rosuvastatin Impurity 146 |
|
|
|
Rosuvastatin Impurity 126 |
|
|
|
(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-di(thiophen -2-yl)acetate |
29461-90-3 |
C18H21NO3S2 |
|
Digoxin Impurity 2 |
|
|
|
DUTP, 100MM SOLUTION |
94736-09-1 |
C9H16N2NaO14P3 |
|
Oxacillin USP Impurity D |
|
|
|
Oxacillin sodium EP impurity B |
|
|
|
Meropenem Impurity MAP-B |
|
|
|
SODIUM CAMPTOTHECIN |
25387-67-1 |
C20H17N2NaO5 |
|
(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-L-cysteine |
2238849-52-8 |
C13H15N3O3S |
|
(S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5,12-dihydroxy-7-methoxy-6,11-dioxo-3,4,6,11-tetrahydrotetracene-2-carboxylic acid |
|
|
|
3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1R)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-, (1R,2S,5S)- |
2755812-41-8 |
C23H32F3N5O4 |
|
3-(4-cyanophenoxy)benzyl acetate |
2990481-66-6 |
|
|
Bisoprolol Impurity 53 |
|
|
|
Doxylamine Impurity E |
|
|
|
Phenoxymethylpenicillin Potassium EP Impurity F |
2714805-53-3 |
C15H20N2O4S |
|
Methylprednisolone EP Impurity D1 |
|
|
|
Nirmatrelvir Impurity 13 |
|
|
|
2-Pyridinecarboxamide, 4-hydroxy-N-methyl- (9CI) |
611226-36-9 |
C7H8N2O2 |
|
Bumetanide Impurity 22 |
|
|
|
Rocuronium Bromide Impurity 32 、33 |
|
|
|
Flucloxacillin Sodium Impurity X |
|
|
|
Pitavastatin Impurity 98 |
|
|
|
Perospirone Impurity 29 |
|
|
|
Perospirone Impurity 24 |
|
|
|
Perospirone Impurity 7 |
1002359-81-0 |
|
|
2-methyl-4-(((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14- tetraen-1-yl)oxy)naphthalen-1-yl acetate |
|
|
|
Paxlovid Impurity 17 |
|
|
|
NA |
|
|
|
Cefuroxime Impurity D Δ3-Isomer |
|
|
|
Ampicillin Open-Ring Formylation Impurity |
|
|
|
Faropenem Degradation Impurity A |
|
|
|
2-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid |
|
|
|
(2S)-dimethyl 2-(4-(4-oxobutan-2-yl)benzamido)pentanedioate |
|
|
|
(E)-1-(2,4-difluorostyryl)-1H-1,2,4-triazole |
|
|
|
Peramivir Impurity 22 |
|
|
|
Olaparib Impurity 58 |
848136-41-4 |
C22H21FN4O3 |
|
Fluconazole Impurity 4 |
168479-96-7 |
C10H7F2N3O |
|
Roxatidine Impurity 7 |
876497-65-3 |
C7H6N2O2 |
|
Sparfloxacin Impurity |
126457-99-6 |
C19H21F2N3O3 |
|
Peramivir Impurity 39 |
|
|
|
Imatinib impurity 39 |
|
|
|
7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE |
203395-59-9 |
C13H14BrNO2 |
|
DESMETHYL ATOMOXETINE HYDROCHLORIDE |
881995-46-6 |
C16H19NO.ClH |
|
2-HYDROXY-5-BENZYLOXYACETOPHENONE |
30992-63-3 |
C15H14O3 |
|
2-[(4-METHOXY-3-METHYL-2-PYRIDINYL)-METHYLTHIO]-BENZIMIDAZOLE |
102804-82-0 |
C15H15N3OS |
|
2-[(4-METHYLPIPERAZIN-1-YL)METHYL]BENZONITRILE |
864069-00-1 |
C13H17N3 |
|
Sugammadex sodium Impurity 40 |
|
|
|
Sugammadex sodium Impurity 44 |
|
|
|
Sugammadex sodium Impurity 49 |
|
|
|
Cefazolin Impurity EP-E |
|
|